These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36172059)

  • 21. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
    Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
    Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.
    Agnihotri G; Gross AE; Seok M; Yen CY; Khan F; Ebbitt LM; Gay C; Bleasdale SC; Sikka MK; Trotter AB
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e33. PubMed ID: 36865701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema.
    Stockmann C; Ampofo K; Pavia AT; Byington CL; Sheng X; Greene TH; Korgenski EK; Hersh AL
    Hosp Pediatr; 2015 Dec; 5(12):605-12. PubMed ID: 26526596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.
    Brenneman E; Funaro J; Dicks K; Yarrington M; Lee HJ; Erkanli A; Hung F; Drew R
    JAC Antimicrob Resist; 2023 Feb; 5(1):dlad019. PubMed ID: 36824226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis.
    Andrews MM; von Reyn CF
    Clin Infect Dis; 2001 Jul; 33(2):203-9. PubMed ID: 11418880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ampicillin Plus Ceftriaxone Combined Therapy for
    Herrera-Hidalgo L; Lomas-Cabezas JM; López-Cortés LE; Luque-Márquez R; López-Cortés LF; Martínez-Marcos FJ; de la Torre-Lima J; Plata-Ciézar A; Hidalgo-Tenorio C; García-López MV; Vinuesa D; Gutiérrez-Valencia A; Gil-Navarro MV; De Alarcón A
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Routine Laboratory Tests for Follow up of Patients Receiving Outpatient Parenteral Antimicrobial Therapy Run by Infectious Diseases Fellows.
    Frisby J; Ali N; Niemotka S; Abate G
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
    Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
    N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for
    Castillo-Fernández N; Pérez-Crespo PMM; Salamanca-Rivera E; Herrera-Hidalgo L; de Alarcón A; Navarro-Amuedo MD; Marrodán Ciordia T; Pérez-Rodríguez MT; Sevilla-Blanco J; Jover-Saenz A; Fernández-Suárez J; Armiñanzas-Castillo C; Reguera-Iglesias JM; Natera Kindelán C; Boix-Palop L; León Jiménez E; Galán-Sánchez F; Del Arco Jiménez A; Bahamonde-Carrasco A; Vinuesa García D; Smithson Amat A; Cuquet Pedragosa J; Reche Molina IM; Pérez Camacho I; Merino de Lucas E; Gutiérrez-Gutiérrez B; Rodríguez Baño J; López Cortés LE
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency department visits during outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Shrestha NK; Kim SL; Rehm SJ; Everett A; Gordon SM
    J Antimicrob Chemother; 2018 Jul; 73(7):1972-1977. PubMed ID: 29684172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.
    Allison GM; Muldoon EG; Kent DM; Paulus JK; Ruthazer R; Ren A; Snydman DR
    Clin Infect Dis; 2014 Mar; 58(6):812-9. PubMed ID: 24357220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.
    Kutubi A; O'Brien L; Murphy B; Fitzpatrick P; Hurson C; Rajendran D; Feeney E; Mallon P; Waqas S
    Heliyon; 2023 Apr; 9(4):e15212. PubMed ID: 37113779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outpatient treatment of endocarditis in a clinic-based program in Argentina.
    Stamboulian D
    Eur J Clin Microbiol Infect Dis; 1995 Jul; 14(7):648-54. PubMed ID: 7588859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment.
    Melzer M; Macpherson L; Welch C
    Postgrad Med J; 2017 Jul; 93(1101):382-388. PubMed ID: 27821624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Morgan R; Chelaghma N; Palit J; Keil C; Omer R; Cartwright K; Kritsotakis EI
    J Antimicrob Chemother; 2021 Jul; 76(8):2204-2212. PubMed ID: 33895844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
    Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
    Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.